Literature DB >> 8989296

Cost-utility analysis of contaminated appendectomy wounds.

K J Brasel1, D C Borgstrom, J A Weigelt.   

Abstract

BACKGROUND: The influence of patient preference and treatment costs has not been considered in previous analyses of wound management decisions for contaminated right lower quadrant incisions. STUDY
DESIGN: We performed a decision and cost-utility analysis, conducting a MEDLINE search of the postappendectomy wound infection literature to establish assumptions and assign baseline probability estimates. Institution-specific cost data were obtained, and utility assignments were made by the authors. Studies used to assign baseline probabilities fulfilled the following criteria: perforated appendix or gangrenous appendicitis, use of perioperative antibiotics active against aerobic and anaerobic bacteria, and data stratified by wound management, operative findings, and infection rate.
RESULTS: We constructed a decision tree comparing three methods of wound management for contaminated right lower quadrant incisions: primary closure, delayed primary closure, and secondary closure. Utility (a quality of life measure) was assigned to ultimate health states to incorporate patient preference. We calculated the cost-utility for each method of wound management and found that primary closure was of optimum cost-utility compared with delayed primary closure and secondary closure. To gain one quality-adjusted life year treating a population of patients with contaminated incisions, primary closure saves $22,635 over delayed primary closure and another $22,340 over secondary closure. This decision, tested by two-way sensitivity analyses, was sensitive only to high primary closure infection rates.
CONCLUSIONS: Challenging traditional surgical dogma, cost-utility analysis shows that primary closure is the favored method of management for contaminated right lower quadrant incisions. This analysis is specific to right lower quadrant incisions and the conclusion is valid for all estimated primary infection rates less than 0.27.

Entities:  

Mesh:

Year:  1997        PMID: 8989296

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  9 in total

Review 1.  Laparoscopic totally extraperitoneal versus open preperitoneal mesh repair for inguinal hernia recurrence: a decision analysis based on net health benefits.

Authors:  George Sgourakis; Georgia Dedemadi; Ines Gockel; Irene Schmidtmann; Sophocles Lanitis; Paraskevi Zaphiriadou; Athanasios Papatheodorou; Constantine Karaliotas
Journal:  Surg Endosc       Date:  2013-01-24       Impact factor: 4.584

2.  A computer simulation model of the cost-effectiveness of routine Staphylococcus aureus screening and decolonization among lung and heart-lung transplant recipients.

Authors:  C J Clancy; S M Bartsch; M H Nguyen; D R Stuckey; R K Shields; B Y Lee
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-02-07       Impact factor: 3.267

Review 3.  Infection control in colon surgery.

Authors:  Donald E Fry
Journal:  Langenbecks Arch Surg       Date:  2016-06-27       Impact factor: 3.445

4.  Routine pre-cesarean Staphylococcus aureus screening and decolonization: a cost-effectiveness analysis.

Authors:  Bruce Y Lee; Ann E Wiringa; Elizabeth A Mitgang; Sarah M McGlone; Abena N Afriyie; Yeohan Song; Richard H Beigi
Journal:  Am J Manag Care       Date:  2011-10       Impact factor: 2.229

5.  The potential economic value of a Staphylococcus aureus vaccine among hemodialysis patients.

Authors:  Yeohan Song; Julie H Y Tai; Sarah M Bartsch; Richard K Zimmerman; Robert R Muder; Bruce Y Lee
Journal:  Vaccine       Date:  2012-03-29       Impact factor: 3.641

6.  Open and laparoscopic appendectomy are equally safe and acceptable in children.

Authors:  T Oka; A G Kurkchubasche; J G Bussey; C W Wesselhoeft; T F Tracy; F I Luks
Journal:  Surg Endosc       Date:  2003-12-29       Impact factor: 4.584

7.  Comparison of Superficial Surgical Site Infection Between Delayed Primary Versus Primary Wound Closure in Complicated Appendicitis: A Randomized Controlled Trial.

Authors:  Boonying Siribumrungwong; Anuwat Chantip; Pinit Noorit; Chumpon Wilasrusmee; Winai Ungpinitpong; Pradya Chotiya; Borwornsom Leerapan; Patarawan Woratanarat; Mark McEvoy; John Attia; Ammarin Thakkinstian
Journal:  Ann Surg       Date:  2018-04       Impact factor: 12.969

8.  Estimating the Economic and Clinical Value of Reducing Antimicrobial Resistance to Three Gram-negative Pathogens in Japan.

Authors:  Tetsuya Matsumoto; Oliver Darlington; Ryan Miller; Jason Gordon; Phil McEwan; Takahisa Ohashi; Amer Taie; Akira Yuasa
Journal:  J Health Econ Outcomes Res       Date:  2021-10-06

9.  Estimating the Economic and Clinical Value of Introducing Ceftazidime/Avibactam into Antimicrobial Practice in Japan: A Dynamic Modelling Study.

Authors:  Tetsuya Matsumoto; Akira Yuasa; Ryan Miller; Clive Pritchard; Takahisa Ohashi; Amer Taie; Jason Gordon
Journal:  Pharmacoecon Open       Date:  2022-09-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.